Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Upper Extremity Deep Vein Thrombosis × Rivaroxaban × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Venous Thrombosis 1 Venous Thromboembolism 1 Upper Extremity Deep Vein Thrombosis 1 Recurrence 1 Lung Neoplasms 1 Hemorrhage 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

apixaban 1 Rivaroxaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

London Health Sciences Centre

Phase 4 Completed

Neoplasms, Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡